Biogen Inc. (BIIB)$193.76
Market Cap: 17.85 BCurrency: USD
Research Snapshot
Static fundamentals, valuation context, and investor signals for Biogen Inc. (BIIB).
HEALTHCARE
DRUG MANUFACTURERS - GENERAL
DCF ready
Valuation
10.3x
EV/FCF, 9.7% FCF yield
Quality
5.3%
ROIC, 20.7% FCF margin
Growth
-6.0%
5Y sales (revenue) CAGR
Balance sheet
0.3x
Debt/equity, 2.7x current ratio
Superinvestors
2
Top: Hillman Value Fund (3.8%)
Strengths to research
- Free cash flow margin is healthy at 20.7%.
- Debt/equity looks manageable at 0.3x.
- 10 annual periods are available for trend analysis.
Watchouts
- Five-year revenue trend is negative at -6.0%.
Annual data: 10 periods
Quarterly data: 24 periods
Stock snapshot: May 25, 2026
Static dataset: May 25, 2026
Quality Scorecard
Build-time composite score for BIIB.
Grade F
23
/ 100
Peer Comparison
Target stock against 8 market-cap comparable peers.
Heat map: red worst to green best
| BIIB Target | Biogen Inc. | $17.8B | 22.0x | 10.3x | 5.3% | -6.0% | 20.7% | N/A | N/A | N/A |
| BAYRY | Bayer Ag Sponsored ADR | $26.9B | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| GSK | GSK plc | $79.0B | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| BMY | Bristol-Myers Squibb | $101.9B | 17.2x | 10.6x | 11.1% | 2.5% | 26.7% | N/A | N/A | N/A |
| GILD | Gilead Sciences | $128.0B | 19.8x | 15.4x | 17.9% | 3.6% | 32.1% | N/A | 1.7x | N/A |
| SNY | Sanofi Aventis | $133.3B | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| PFE | Pfizer Inc. | $135.4B | 19.0x | 14.8x | 9.0% | 8.5% | 14.5% | N/A | N/A | N/A |
| OGN | Organon & Co. | $2.3B | 18.7x | 19.2x | 2.0% | -1.0% | 8.7% | 53.3% | N/A | N/A |
| AMGN | Amgen | $150.6B | 23.8x | 24.2x | 12.2% | 7.6% | 22.0% | N/A | 3.2x | N/A |
Financial Charts
No financial data available for BIIB (annual).
2 superinvestors own BIIB
Current quarter ownership and quarter-over-quarter share changes.
Superinvestor ownership
| Fund | Shares | Value | % Portfolio | QoQ Change |
|---|---|---|---|---|
| Samantha McLemore Patient Capital Management | 379,741 | $70M | 2.60% | 0.0% |
| Hillman Value Fund Hillman Value Fund | 29,540 | $5M | 3.76% | 0.0% |